APA (7th ed.) Citation

König, M., Lorentzen, Å. R., Torgauten, H. M., Tran, T. T., Schikora-Rustad, S., Vaage, E. B., . . . Nygaard, G. O. (2023). Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: The relevance of time since last rituximab infusion and first experience from sporadic revaccinations. Journal of neurology, neurosurgery and psychiatry, 94(1), 19-22. https://doi.org/10.1136/jnnp-2021-327612

Chicago Style (17th ed.) Citation

König, Marton, et al. "Humoral Immunity to SARS-CoV-2 MRNA Vaccination in Multiple Sclerosis: The Relevance of Time Since Last Rituximab Infusion and First Experience from Sporadic Revaccinations." Journal of Neurology, Neurosurgery and Psychiatry 94, no. 1 (2023): 19-22. https://doi.org/10.1136/jnnp-2021-327612.

MLA (9th ed.) Citation

König, Marton, et al. "Humoral Immunity to SARS-CoV-2 MRNA Vaccination in Multiple Sclerosis: The Relevance of Time Since Last Rituximab Infusion and First Experience from Sporadic Revaccinations." Journal of Neurology, Neurosurgery and Psychiatry, vol. 94, no. 1, 2023, pp. 19-22, https://doi.org/10.1136/jnnp-2021-327612.